纳米反应器
材料科学
加强
铂金
纳米技术
纳米颗粒
催化作用
生物化学
生物
哲学
语言学
作者
Fu Xu,Wen Yin,Dao Shi,Yifan Yang,Suisui He,Jun Hai,Zhenqing Hou,Zhongxiong Fan,Dekui Zhang
标识
DOI:10.1021/acsami.1c06668
摘要
The synergistic nanotheranostics of reactive oxygen species (ROS) augment or phototherapy has been a promising method within synergistic oncotherapy. However, it is still hindered by sophisticated design and fabrication, lack of a multimodal synergistic effect, and hypoxia-associated poor photodynamic therapy (PDT) efficacy. Herein, a kind of porous shuttle-shape platinum (IV) methylene blue (Mb) coordination polymer nanotheranostics-loaded 10-hydroxycamptothecin (CPT) is fabricated to address the abovementioned limitations. Our nanoreactors possess spatiotemporally controlled O 2 self-supply, self-sufficient singlet oxygen ( 1 O 2 ), and outstanding photothermal effect. Once they are taken up by tumor cells, nanoreactors as a cascade catalyst can efficiently catalyze degradation of the endogenous hydrogen peroxide (H 2 O 2 ) into O 2 to alleviate tumor hypoxia. The production of O 2 can ensure enhanced PDT. Subsequently, under both stimuli of external red light irradiation and internal lysosomal acidity, nanoreactors can achieve the on-demand release of CPT to augment in situ mitochondrial ROS and highly efficient tumor ablation via phototherapy. Moreover, under the guidance of near-infrared (NIR) fluorescent imaging, our nanoreactors exhibit strongly synergistic potency for treatment of hypoxic tumors while reducing damages against normal tissues and organs. Collectively, shuttle-shape platinum-coordinated nanoreactors with augmented ROS capacity and enhanced phototherapy efficiency can be regarded as a novel tumor theranostic agent and further promote the research of synergistic oncotherapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI